# Carbidopa and levodopa

NDC: 0093-9702
Generic name: Carbidopa and levodopa
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220118

FDA application: ANDA074260

## Active ingredients

- CARBIDOPA HYDRATE: 25 mg/1
- LEVODOPA: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-9702"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-9702
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ace5274-b6cf-414c-b9c0-f60e28a9cea5